Substitute For
HOUSE BILL NO. 4249
A bill to amend 2016 PA 281, entitled
"Medical marihuana facilities licensing act,"
by amending sections 502 and 504 (MCL 333.27502 and 333.27504), section 502 as amended by 2018 PA 648 and section 504 as amended by 2018 PA 10, and by adding section 407b.
the people of the state of michigan enact:
Sec. 407b. A processor that violates section 502(7) or a provisioning center that violates section 504(4)(f) is guilty of a misdemeanor punishable by a fine of not more than $10,000.00.
Sec. 502. (1) A processor license authorizes purchase of marihuana only from a grower and sale of marihuana-infused products or marihuana only to a provisioning center or another processor.
(2) Except as otherwise provided in section 505 and this subsection, a processor license authorizes the processor to transfer marihuana only by means of a secure transporter. A processor license authorizes a processor to transfer marihuana without using a secure transporter to a grower or provisioning center if both of the following are met:
(a) The grower or provisioning center occupies the same location as the processor and the marihuana is transferred using only private real property without accessing public roadways.
(b) The processor enters each transfer into the statewide monitoring system.
(3) To be eligible for a processor license, the applicant and each investor in the processor must not have an interest in a secure transporter or safety compliance facility.
(4) Until December 31, 2018, for a period of 30 days after the issuance of a processor license and in accord with rules, a processor may transfer any of the following that are lawfully possessed by an individual formerly registered as a primary caregiver who is an active employee of the processor:
(a) Marihuana plants.
(b) Usable marihuana.
(5) A processor shall comply with all of the following:
(a) Until December 31, 2021, have, or have as an active employee an individual who has, a minimum of 2 years' experience as a registered primary caregiver.
(b) While holding a license as a processor, not be a registered primary caregiver and not employ an individual who is simultaneously a registered primary caregiver.
(c) Enter all transactions, current inventory, and other information into the statewide monitoring system as required in this act, rules, and the marihuana tracking act.
(6) This act does not prohibit a processor from handling, processing, marketing, or brokering, as those terms are defined in section 2 of the industrial hemp research and development act, MCL 286.842, industrial hemp.
(7) A processor shall not process marihuana intended for inhalation or a marihuana-infused product intended for inhalation if the marihuana or marihuana-infused product contains or has been combined with any of the following:
(a) Vitamin E acetate.
(b) Any other ingredient unless 1 of the following applies:
(i) The ingredient is a botanically derived terpene that is chemically identical to a terpene derived from the plant Cannabis sativa L.
(ii) Both of the following conditions are met:
(A) The ingredient is approved by the Food and Drug Administration for inhalation.
(B) The concentration of the ingredient in the marihuana or marihuana-infused product is equal to or less than the maximum concentration approved by the Food and Drug Administration.
Sec. 504. (1) A provisioning center license authorizes the purchase or transfer of marihuana only from a grower or processor and sale or transfer to only a registered qualifying patient or registered primary caregiver. Except as otherwise provided in section 505 and this subsection, all transfers of marihuana to a provisioning center from a separate marihuana facility must be by means of a secure transporter. A transfer of marihuana to a provisioning center from a marihuana facility that occupies the same location as the provisioning center does not require a secure transporter if the marihuana is transferred to the provisioning center using only private real property without accessing public roadways.
(2) A provisioning center license authorizes the provisioning center to transfer marihuana to or from a safety compliance facility for testing by means of a secure transporter or as provided in section 505.
(3) To be eligible for a provisioning center license, the applicant and each investor in the provisioning center must not have an interest in a secure transporter or safety compliance facility.
(4) A provisioning center shall comply with all of the following:
(a) Sell or transfer marihuana to a registered qualifying patient or registered primary caregiver only after it has been tested and bears the label required for retail sale.
(b) Enter all transactions, current inventory, and other information into the statewide monitoring system as required in this act, rules, and the marihuana tracking act.
(c) Before selling or transferring marihuana to a registered qualifying patient or to a registered primary caregiver on behalf of a registered qualifying patient, inquire of the statewide monitoring system to determine whether the patient and, if applicable, the caregiver hold a valid, current, unexpired, and unrevoked registry identification card and that the sale or transfer will not exceed the daily and monthly purchasing limit established by the medical marihuana licensing board marijuana regulatory agency under this act.
(d) Not allow the sale, consumption, or use of alcohol or tobacco products on the premises.
(e) Not allow a physician to conduct a medical examination or issue a medical certification document on the premises for the purpose of obtaining a registry identification card.
(f) Not sell marihuana intended for inhalation or a marihuana-infused product intended for inhalation if the marihuana or marihuana-infused product contains or has been combined with any of the following:
(i) Vitamin E acetate.
(ii) Any other ingredient unless 1 of the following applies:
(A) The ingredient is a botanically derived terpene that is chemically identical to a terpene derived from the plant Cannabis sativa L.
(B) Both of the following conditions are met:
(I) The ingredient is approved by the Food and Drug Administration for inhalation.
(II) The concentration of the ingredient in the marihuana or marihuana-infused product is equal to or less than the maximum concentration approved by the Food and Drug Administration.